Effect of bombesin upon plasma somatostatin-like immunoreactivity, insulin and glucagon in normal and chemically sympathectomized dogs.
The present study was designed to determine the effects of intravenously infused bombesin (10 ng/kg/min) upon basal and postprandial plasma somatostatin-like immunoreactivity (SLI), glucagon, insulin and triglyceride levels in normal (n = 12) and chemically sympathectomized (n = 11) dogs. Basal plasma SLI, glucagon and insulin levels rose significantly during the infusion of bombesin in the normal dogs, and this was not altered by chemical sympathectomy. Bombesin infusion enhanced the postprandial SLI response, while attenuating the postprandial glucagon response by 50% and the insulin response in the early postprandial phase of the meal. Sympathectomy did not significantly alter the basal levels of these polypeptides, but augmented the postprandial plasma SLI response during the first 90 min, and reduced the postprandial glucagon response during the infusion of bombesin. The postprandial insulin response was not affected by sympathectomy. In both normal and chemically sympathectomized dogs the rise in postprandial triglyceride levels was attenuated by bombesin infusion.
D000818:Animals; D001839:Bombesin / Q000494:pharmacology*; D004285:Dogs; D005215:Fasting; D005502:Food; D006892:Hydroxydopamines / Q000494:pharmacology; D007328:Insulin / Q000097:blood*; D007700:Kinetics; D010455:Peptides / Q000097:blood* / Q000494:pharmacology*; D013004:Somatostatin / Q000097:blood*; D013564:Sympathetic Nervous System / Q000187:drug effects*; D014280:Triglycerides / Q000097:blood
D006892:Hydroxydopamines; D007328:Insulin; D010455:Peptides; D014280:Triglycerides; C029993:somatostatin-like peptides; D013004:Somatostatin; D001839:Bombesin